ZOU et al. [32] reported that PVT1 affects the proliferation and invasion of ovarian cancer cells by affecting the expression of SOX2, and other studies have found that PVT1 can enhance the resistance of ovarian cancer to cisplatin [33, 34]. Here, SOX2 is linked to ovarian carcinoma.